Testing effectiveness (Phase 2)Ended earlyNCT04950114
What this trial is testing
An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases
Who this might be right for
Kidney DiseasesGlomerulosclerosisFocal Segmental Nephrosis+4 more
Goldfinch Bio, Inc. 31